Search results - 8 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses, against hospitalisation due to COVID-19 and COVID-19 related deaths in resident ...
Surveillance of COVID-19 mortality in Belgium, epidemiology and methodology during 1st and 2nd wave (March 2020- 14 February 2021)
Coronavirus COVID-19 mortality Surveillance Abstract: This report provides epidemiological figures about the characteristics of COVID-19 deaths during the first wave (1 March 2020 until 21 June 2020), the inter ...
Excess mortality during the first and second waves of the COVID-19 epidemic in Belgium
distancing, etc.) and non-pharmaceutical interventions (e.g., hand hygiene, personal protective equipment, etc.), it is possible that the excess mortality during this period would have been greater. Mortality ...
Resultaten van de 6e nationale campagne ter bevordering van de handhygiëne in ziekenhuizen, 2014-2015
over 111,000 (95% confidence interval 73,556-159,292) infected patients in this setting [2]. Hand hygiene (HH) compliance has been recognised as the most important factor in preventing transmission of ...
Résultats de la 5ème campagne nationale pour la promotion de l'hygiène des mains dans les hôpitaux 2013
pediatric/neonatal services (Figure 6). Though the focus of this campaign was on ‘before patient contact’ and ‘before aseptic tasks’, compliance rate was still very high for ‘after patient contact’ and ‘exposure to ...
Resultaten van de 5de Nationale campagne ter bevordering van de Handhygiëne (HH) in Ziekenhuizen, 2013
pediatric/neonatal services (Figure 6). Though the focus of this campaign was on ‘before patient contact’ and ‘before aseptic tasks’, compliance rate was still very high for ‘after patient contact’ and ‘exposure to ...
Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for Tetanus Vaccine (Adsorbed) Batch 3).
assays. This compared favourably with the calibration of the3rd IS / BRP batch 2 where the inter-laboratory GCV was 36 % and 42 % in guinea pigs and mice, respectively.For Preparation B, the GM potency ...
Calibration of Human Coagulation Factor VII Concentrate Ph. Eur. BRP Batch 2
assigned potency of 8.2 IU /vial for the chromogenic assay method. Stocks of this BRP are dwindling and areplacement batch needs to be established.A candidate material was produced by a manufacturer from ...